Cookies
This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
Organised by the 118ͼ¿â Executive Committee
2nd June |
Monday, Day 1 |
|
|
1200 |
Registration and refreshments |
1300 1305 |
Welcome Address –Adrian Harris (University of Oxford) PPI Speaker: Elspeth Banks, (Independent Cancer Patients' Voice) |
1315 |
Opening Keynote: Steve Jackson (Cancer Research UK Cambridge Institute) Cellular responses to DNA damage: mechanistic insights and therapeutic implications |
|
Session 1: Genes, Mutation and Repair
|
1400 |
Jo Morris (University of Birmingham) TBC |
1430 |
Helen Bryant (University of Sheffield) DNA repair inhibitors - beyond PARP and BRCAness |
1500
1515
1530 |
Short talk
Short talk
Coffee/Tea
|
|
|
1600 |
Kristian Helin, (ICR, London) New Therapeutic targets for Acute Myeloid Leukaemia |
1630 |
Susan Gasser, (ISREC, Lausanne, Switzerland) Roles of chromatin and nucleosome remodelers in genome stability |
1700
1715
1930 |
118ͼ¿â AstraZeneca Young Scientist Award 2023 Luca Magnani, (ICR, London) Sleepwalking through evolution: a tale of dormancy and hormone dependent breast cancer Welcome drinks and finger buffet
Poster Session 1 (Odd Numbers)
Speakers’ Dinner |
|
|
3rd June |
Tuesday, Day 2 Session 2: The Tumour Ecosystem
|
0900 |
Kairbaan Hodivala-Dilke (Barts Cancer Institute, QMUL) Tumour blood vessels and b3-integrin: Converging stories |
0930 |
Leanne Li (Francis Crick Institute, London) Behind the scenes: Neuronal orchestration of the tumour microenvironment |
1000 |
Short talk
|
1015 |
Short Talk
|
1030 |
Tea/Coffee
|
1100 |
Derek Mann (University of Newcastle) Manipulating neutrophils to repgroamme the tumour microenvironment of hepatocellular carcinoma |
1130
1200 |
Erik Sahai (Francis Crick Institute, London) Modelling the tumour - stroma interface 118ͼ¿â Chris Marshall Prize for Cell Signalling TBC Yaiza Jung Garcia (Lothian University, Edinburgh) LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion |
1215 |
Lunch Posters and Exhibition (12.40 to 13.00 Commercial Workshop)
|
|
Session 3: Immune cells and immunotherapy
|
|
|
1400
|
Mark Cragg (University of Southampton) Engineering antibodies for immune stimulation |
1430 |
Santiago Zeleny (Cancer Research UK Manchester Institute) The dual role of inflammation in cancer immunity |
1500 |
Short Talk
|
1515 |
Short talk
|
1530 |
Coffee/Tea
|
1600 |
Eileen Parkes (University of Oxford) Chromosomal instability shapes the tumour microenvironment |
1630 |
Ed Roberts (Cancer Research UK Scotland Institute, Glasgow) Failure to recruit lymph node resident cDC1 results in poorly functional anti-tumour CD8 T cell responses |
1700
1900 |
Drinks Reception Poster Session 2 (Even Numbers)
Conference Dinner (Venue to be confirmed)
|
4thJune |
Wednesday, Day 3 Session 4: Models, Screening, Profiling and Imaging
|
|
|
0900 |
Mathew Garnett (Sanger Institute, Cambridge) Mapping Cncer Dependencies to Guide Precision Cancer Medicine |
0930 |
Philip Dunne (Queens University, Belfast) The molecular and phenotypic landscapes in colorectal cancer |
1000 |
Short Talk (Cardiff University)
|
1015
|
Short Talk
|
1030 |
Tea/Coffee |
|
|
1100
1130 |
Eugenia Piddini (University of Bristol) p53-mediated stem cell competition: Insights into mechanisms of clonal dominance Noor Gammoh (University of Edinburgh) Modelling the role of autophagy in brain tumour development
|
1200
1230
|
118ͼ¿â/AstraZeneca Frank Rose Award (2022) Stephen Sammut (ICR) Stephen-John Sammut, (ICR, London) Ending uncertainty: predicting response to breast cancer treatment using tumour profiling and AI.
Lunch
|
|
Session 5: Novel Therapeutic Strategies and Early Detection
|
|
|
1315
1345
|
Pascal Meier (ICR, London) The Power of Death: Harnessing Immunogenic Cell Death in Cancer Louise Fets (MRC/Imperial College London) Heterogeneous drug accumulation in cancer - why concentration matters |
1415
1430 |
Short Talk
Short Talk |
|
|
1445
1515
1545 |
Tea/Coffee
Alan Parker (Cardiff University) Development of precision virotherapies for "in-tumour" expression of theapeutics Closing Keynote: Rene Bernards (Netherlands Cancer Institute, Amsterdam) Behave or die, a novel approach to cancer therapy |
1630 |
Awards Ceremony and Closing Remarks |
|
|
|
|
If you have any special dietary requirements - please let us know.
Data
Your email address will be retained in our electronic registration database and used for correspondence from the 118ͼ¿â.
List of Participants
If you attend, we will include your name and country in the printed programme book unless you request to be removed.
Please click below if you agree for your email address to be included in the printed List of Participants that is given to all attendees and exhibitors.
Don't Include
Include
Please note: you have selected for your email address NOT to appear in the List of Participants.
You can click above to change this.
118ͼ¿â is a registered charity in England and Wales (289297)
Registered address:
c/o Leeds Institute of Medical Research at St James’s, Cancer Genetics Building,
St James's University Hospital, Beckett Street, Leeds LS9 7TF
Home / Privacy Policy & Cookies / Terms of use / Site map / Admin
© 2018 - 2024 118ͼ¿â - The 118ͼ¿â. All rights reserved.
This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.